Pfizer's board of directors set the company's dividend policy on June 6, 2026, citing patent expirations and R&D challenges.
3 reports, 2 independent
Updated Aug 27
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer's board of directors set the company's dividend policy on June 6, 2026, citing patent expirations and R&D challenges.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Keep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
Related events
- Bristol-Myers Squibb and Pfizer are co-marketing Eliquis, while both companies are noted as dividend payers.
- Pfizer, Johnson & Johnson, and Merck are facing significant industry pressures due to patent cliffs and market pricing demands.
- Pfizer and Eli Lilly are being discussed as potential dividend investment targets.